The Asian Pacific Association for the Study of the Liver [APASL] » Archive » Elimination statement signed and shared with WHO, ‪‎EASL‬, AASLD, and ALEH!

What's New

2026/01/16
Abstract Submission Deadline is Jan 20 !! APASL Oncology 2026 Tokyo !!

Abstract Submission Deadline has been extended to Jan 20, 2026 !! APASL Oncology 2026 Tokyo is waiting for your active … [Read more]
2026/01/13
APASL STC 2026 New Delhi will be held on Jan 30-31 !!

With the theme of Wilson India 2026~ Integrating Research into Clinical Practice in Wilson Disease ~, APASL STC 2026 New … [Read more]
2026/01/09
Call for Bidding !! APASL Annual Meeting in 2029 and STCs in 2027

Call for Bidding !! APASL Annual Meeting in 2029 and APASL STC/Oncology in 2027 At this time, we would like … [Read more]
2026/01/08
Please check out the latest article on Hepatology International !!

Read the findings from the ANCHOR randomized controlled trial, evaluating the efficacy and safety of combination therapy with entecavir, peginterferon … [Read more]
2026/01/06
Call for Abstracts of APASL-ONCOLOGY 2026 TOKYO!

APASL-ONCOLOGY 2026 TOKYO Abstract submission deadline has been extended until January 20, 2026 !　 https://www.apasl.info/wp-apasl/wp-content/uploads/2026/01/f1d9ce63a105a76047a73f8c42cbbb96.mp4 Dear Colleagues, A Happy New … [Read more]

What's New